Table:
begin	end	state
1	32	cytoplasmic
33	56	transmembrane
57	61	non-cytoplasmic
62	84	transmembrane
85	104	cytoplasmic
105	128	transmembrane
129	166	non-cytoplasmic
167	185	transmembrane
186	196	cytoplasmic
197	216	transmembrane
217	236	non-cytoplasmic
237	259	transmembrane
260	273	cytoplasmic
274	294	transmembrane
295	324	non-cytoplasmic
325	344	transmembrane
345	374	cytoplasmic
375	392	transmembrane
393	397	non-cytoplasmic
398	418	transmembrane
419	430	cytoplasmic
431	449	transmembrane
450	454	non-cytoplasmic
455	473	transmembrane
474	484	cytoplasmic

Input:
>WP_025765060.1 NCBI__GCF_000566685.1:WP_025765060.1
MASQLWFKKPIEKLLQESTGEENQLKRSLSSLSLVALGIGAIIGAGLFSLTGIAAAEHSG
PAVTISFIVAAVGCGFAGLCYAEFASMIPIAGSAYTYSYATMGEFVAWIIGWDLVLEYAL
GAATVSVSWSRYLLEFLSKFDIHLPTQLVSSPFEVLTLSDGTIIDNGIINLPAILIVWML
SLLLIRGTEGSAYLNNFLVILKVAVVLIFIGLGWSHINPENYVPYIPENTGNYENFGWSG
IATGAAVVFFAFIGFDAVSTAAQEAKNPQKGMPIGILGSLIVCTILYVLFAHVMTGLVNY
KEFANDAKPAATAFAATGYDSLQTGLIVAILAGYTSVMLVMLLGQSRVFYSMSKDGLLPK
FFSEIHPKFSTPWKTNIFFMLFVSIFAGFVPVSDLGHMVSIGTLFAFSLVCVGVWMLRVK
RPDLPRSFRTPLVPFVPLMGIIVCVYLMYSLPIESWYRLAIWLALGLAIYFFYGKKNSKL
GKEQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server